KEYNOTE SPEAKERS
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD
Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA
Susan Dentzer
President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC
Christopher B. Harwood, JD
Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney’s Office, Southern District of New York, Former Assistant US. Attorney, US Attorney’s Office for the District of Columbia, US Department of Justice, New York, NY
Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
Rachael Honig, JD
First Assistant US Attorney, US Attorney’s Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
Gregg Shapiro, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA
Sally Q. Yates, JD
Partner, King and Spalding, Former Acting Attorney General, Former Deputy Attorney General, Former Assistant US Attorney, US Attorney’s Office, Northern District of Georgia, US Department of Justice, Washington, DC
FEATURING AN INVITATION-ONLY CCO ROUNDTABLE
AND DAY III INDUSTRY-ONLY PLENARY ROUNDTABLE
FEATURED FACULTY
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL
Eric Baim, JD
Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA
Minna Bak, MBA
Senior Manager, Helio Health Group, New York, NY
Ann Beasley, JD
Director, Navigant Consulting; Former Senior Vice President, Chief Compliance Officer, Biogen; Boston, MA
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC
Kathleen Boozang
Dean and Professor of Law at Seton Hall Law, Newark, NJ
Christine N. Bradshaw, JD
Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
Joseph Calarco
Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA
Christie Camelio
Vice President and US Healthcare Compliance Officer, Celgene Corporation, Summit, NJ
Katherine Cartwright Norris, MPA
Director, Berkeley Research Group, Former Senior Director, Compliance, and Integrity Programs, NSF Health Sciences, Former Director, Corporate Compliance, Spectranetics, Former Manager, Corporate Compliance, King, Washington, DC
Brian Conner
Vice President, Head of Corporate Compliance, Strongbridge Biopharma plc, Trevose, PA
Thomas Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
Clarissa Crain
Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
BJ D’Avella
Senior Manager, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, Atlanta, GA
Mark A. DeWyngaert, MBA, PhD
Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY
Jill Fallows-Macaluso, JD
Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ
Margaret Feltz, JD, MA
Executive Director, Acting Chief Compliance Officer, Ethics & Compliance, Purdue Pharma L.P., Former Co-chair, PCF Pharma Compliance Congress, Stamford, CT
Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL
Paul Flanagan, JD
Assistant Professor of Law, Thomas R. Kline School of Law, Drexel University, Former Chief Compliance and Privacy Officer, 21st Century Oncology, West Chester, PA
Alex Ganz, JD
Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY
Jonathan Glazier, JD, MBA
Head of Legal Compliance, Philips North America LLC, Former Senior Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA
Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
Kate Heinzelman, JD
Counsel, Sidley Austin LLP, Former Deputy General Counsel, US Department of Health and Human Services, Former Special Assistant and Associate Counsel to President Barack Obama, Washington, DC
Christine Hood
Director, Learning and Development, Chiesi, Former District Sales Manager, Boehringer Ingelheim, Former Sales Trainer, Biovail, Apex, NC
Casey J. Horton, CFE
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant Consulting, Chicago, IL
Michael Joachim, JD
Global Business Partner, Ethics & Business Integrity, Sanofi Genzyme, Former Assistant General Counsel, Blue Cross Blue Shield of Massachusetts, Cambridge, MA
Marci Juneau, MBA
Partner, Helio Health Group, Atlanta, GA
Jonathon Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ
Puja Leekha, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker, Deerfield, MI
Vickie L. McCormick
Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
Kathleen Meriwether, JD
Principal, Fraud Investigation and Dispute Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
Brian Miller, PhD
Director Compliance Training and Documentation, Otsuka, Former Senior Manager of Learning Technologies, AstraZeneca, Former Associate Director Learning Design & Technology, Merck, Princeton, NJ
John Patrick Oroho, JD
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
Amy Pawloski
Compliance Officer – Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA
Perri Pomper
Director – Ethics and Compliance Strategy & Education at Novo Nordisk
Kelly N. “Nikki” Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
Jeffrey Rosenbaum, MBA
Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA
Michael Shaw, JD
Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline; Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services; Former Member, PCF Executive Committee; Philadelphia, PA
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA
Laura (Munns) Skinner, MBA
Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX
John Smollen, MA, JD
Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA
Oliver Steck
Principal, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY
Ann-Marie Tejcek, MA
Senior Director Ethics & Compliance, USA/Canada, Eli Lilly and Company, Indianapolis, IN
Brian Van Hoy
Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services; Washington, DC
Donna White, CCEP
Vice President, Contracts & Compliance, Chiesi USA, Inc.; Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics; Cary, NC
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC; Editor, Life Science Compliance Update; Senior Fellow & Adjunct Professor, Life Sciences Compliance at Mitchell Hamline School of Law, West Chester, PA
PARTICIPATION OPTIONS
TRADITIONAL ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
LIVE AND ARCHIVED WEBCAST PARTICIPATION
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office.
2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 – 16, 2018
Hotel Savoyen
Vienna, Austria
www.InternationalPharmaCongress.com
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 – 12, 2018
Singapore
www.AsianPharmaCongress.com
NINETEENTH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 – 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
2007 – Brussels
2008 – Paris
2009 – Rome
2010 – Berlin
2011 – Istanbul
2011 – Singapore
2012 – Budapest
2012 – Shanghai
2012 – São Paulo
2013 – Madrid
2013 – Kuala Lumpur
2014 – Shanghai
2014 – Dubai
2014 – Mexico City
2015 – Manila
2016 – Warsaw
2017 – Lisbon
2018 – Vienna